Enhanced Recovery After Surgery (ERAS) in Cardiac Surgery: From Evidence to Precision Perioperative Medicine
- 1Department of Anesthesiology and Critical Care, Clínica Universidad de Navarra, 31008 Pamplona, Spain
Abstract
Cardiac surgery is increasingly performed in older, frailer patients with multimorbidity, making postoperative recovery dependent not only on technical success but also on the quality of perioperative care. Enhanced Recovery After Surgery (ERAS) programs address this challenge through coordinated preoperative optimization, attenuation of surgical stress, organ protection, opioid-sparing analgesia, early mobilization, and structured discharge. This narrative review critically appraises ERAS in cardiac surgery and organizes the evidence across the perioperative pathway. Available studies associate complete ERAS programs with modest reductions in intensive care and hospital length of stay and possible reductions in overall complications, but evidence certainty is limited by heterogeneous bundles, single-center designs, and predominance of observational studies. Component-level evidence is strongest or clinically most relevant for frailty assessment, Patient Blood Management, multimodal analgesia, oxygen delivery-guided perfusion, delirium prevention, and early mobilization, although universal thresholds and isolated technologies should be avoided. Successful implementation depends on multidisciplinary governance, explicit responsibilities, adherence measurement, audit, and patient-centered outcomes. Future development should retain a standardized core while allowing transparent adaptation to baseline risk and observed response. Precision perioperative approaches remain hypothesis-generating and require external validation, clinical impact evaluation, assessment of equity, and demonstration of cost-effectiveness before routine adoption.
Related
- Perioperative inflammation in gynecologic oncology: nursing strategies for enhanced recovery and complication prevention
- IMpact of PerioperAtive KeTamine on Enhanced Recovery After abdominal Surgery (IMPAKT ERAS). Comment on Br J Anaesth 2025; 135: 1770–8
- Perioperative parameters to consider for enhanced recovery in surgery (ERS) in gynecology (excluding breast surgery)
- Enhanced Recovery After Surgery (ERAS) pathways versus conventional perioperative care for colorectal resection.
- Remimazolam for Precision Sedation and Anaesthesia in Vulnerable Populations: A Narrative Review of Pharmacological Mechanisms, Stratified Clinical Evidence, and Individualised Perioperative Strategies
BibTeX
@article{olavide2026enhanced,
title = {{Enhanced Recovery After Surgery (ERAS) in Cardiac Surgery: From Evidence to Precision Perioperative Medicine}},
author = {Isidro Olavide and Pablo Montero-López and Marc Vives},
journal = {Journal of Clinical Medicine},
year = {2026},
month = nov,
doi = {10.3390/jcm15218582},
url = {https://www.mdpi.com/2077-0383/15/21/8582},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Enhanced Recovery After Surgery (ERAS) in Cardiac Surgery: From Evidence to Precision Perioperative Medicine
AU - Isidro Olavide
AU - Pablo Montero-López
AU - Marc Vives
PY - 2026
DA - 2026/11/04
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218582
UR - https://www.mdpi.com/2077-0383/15/21/8582
AB - Cardiac surgery is increasingly performed in older, frailer patients with multimorbidity, making postoperative recovery dependent not only on technical success but also on the quality of perioperative care. Enhanced Recovery After Surgery (ERAS) programs address this challenge through coordinated preoperative optimization, attenuation of surgical stress, organ protection, opioid-sparing analgesia, early mobilization, and structured discharge. This narrative review critically appraises ERAS in cardiac surgery and organizes the evidence across the perioperative pathway. Available studies associate complete ERAS programs with modest reductions in intensive care and hospital length of stay and possible reductions in overall complications, but evidence certainty is limited by heterogeneous bundles, single-center designs, and predominance of observational studies. Component-level evidence is strongest or clinically most relevant for frailty assessment, Patient Blood Management, multimodal analgesia, oxygen delivery-guided perfusion, delirium prevention, and early mobilization, although universal thresholds and isolated technologies should be avoided. Successful implementation depends on multidisciplinary governance, explicit responsibilities, adherence measurement, audit, and patient-centered outcomes. Future development should retain a standardized core while allowing transparent adaptation to baseline risk and observed response. Precision perioperative approaches remain hypothesis-generating and require external validation, clinical impact evaluation, assessment of equity, and demonstration of cost-effectiveness before routine adoption.
SN - 2077-0383
ER -